Loading...

SAKAR Sakar Healthcare Ltd Expansion Plans Announcement

Skr

SKR

Sakar Healthcare Ltd

(SAKAR)

2025 Announcement

Q4 FY26 earnings conference...

Strategic alliance

SEBI Takeover Disclosure

Conference call recording

Audited Results

Consolidated Financial Results

Regulatory Compliance

Conference call schedule

Secretarial Audit Appointment

Audited Financial Results (...

Auditor Resignation

Award / Recognition

Regulatory Compliance

Trading window closure

Results clarification

Transcript of earnings conf...

Conference Call Updates

Investor Presentation

Conference Call

Unaudited financial results

Conference Call Schedule

Unaudited Financial Results

Board meeting outcome

Regulatory clarification

Regulatory Compliance Update

Geographic Expansion

Investor Meeting

Con-call Transcript

Audio Recording Link

Investor Presentation

Q2 Financial Results

Board Meeting Outcome

Quarterly Results

Conference Call Scheduled

New Product Authorizations

Regulatory Compliance

Committee Reconstitution

Management Changes

Director Resignation

Management Changes

Trading Window Closure

Director Cessation

Director Cessation

Director Cessation

Director Appointments

AGM Results Submitted

Annual General Meeting

AGM Notice Publication

Annual General Meeting

Newspaper Publication

New Appointment

Management Appointment

Management Appointment

Director Appointment

Director Appointment

Director Appointment

Financial Results Submitted

Board Meeting Outcome

Oncology Injection Approvals

Regulatory Compliance

Disclosure Submission

Trading Window Closure

Second MA Granted

Equity Shares Allotment

Equity Shares Allotted

No Fund Deviation

Quarterly Results

Board Meeting Outcome

Disclosure Submission

Oncology Injection Approval

Oncology Export Agreements

Certificate Confirmation

Trading Window Closure

Oncology Product Transfer

No Deviation Reported

Financial Results Q3

Financial Results Submitted

Board Meeting Results

Regulatory Certificate

RTA Name Change

Equity Shares Allotment

Board Meeting Outcome

Trading Window Closure

Top 10 Recognition

Investor Meet Announcement

Board Meeting Clarification

Financial Results Update

Financial Results

Securities Confirmation

Trading Window Closure

Management Re-Appointment

Management Re-Appointment

AGM Minutes Released

AGM Results Reported

Annual General Meeting

AGM Announcement

Annual General Meeting

Financial Results Q2

Financial Results Q2

Publication Notification

Board Meeting Outcome

Confidentiality Agreement

Certificate Submission

Submission of Dossiers

Trading Window Closure

ISO 9001:2015 Certification

Financial Results Submission

Financial Results Approval

Agreement Expansion

Disclosure Declaration

Certificate Submission

Trading Window Closure

Approval Received

Financial Results Publication

Deviations in Fund Utilization

Financial Results Submission

Financial Results

Patent for IMATINIB prepara...

Regulation Certificate

Board Meeting Outcome

Allotment of Equity Shares ...

Appointments of Directors

General Meeting Results

EGM Proceedings

Disclosure of Related Party...

Statement of Deviation/Vari...

Certificate Submission

Trading Window Closure

Appointment of Director

Allotment of Securities

Financial Results Submission

EGM - Increase in Authorize...

Newspaper Publication

Share Subscription Agreemen...

Board Approvals

Approved Equity Share Issue

Equity Shares Issuance

Share Capital Increase and ...

External Links:

Data:

Sakar Healthcare becomes Accord’s EU Imatinib supplier after EMA variation approval, marking a strategic geographic expansion and potential upswing in top-line growth from overseas product supply.

AI Assistant

Sakar Healthcare Ltd

2025

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.